Viewing Study NCT05762393


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2025-12-25 @ 11:30 PM
Study NCT ID: NCT05762393
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-02
First Post: 2023-02-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar
Sponsor: International Vaccine Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module